Last edition
News about Global Pharma
ProductLife Group Acquires Herax Life Science to Boost R&D Business
This acquisition unites HERAX Life Science and PLG under a shared commitment to accelerate drug development, streamline clinical trials, and ensure the highest standards of safety and compliance.
Global Pharma | 27/02/2025 | By Aishwarya | 291
Glenmark Pharmaceuticals Inc., USA, has launched Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial, securing 180 days of CGT exclusivity.
Global Pharma | 27/02/2025 | By Manvi | 433
Lupin Secures Place in S&P Global Sustainability Yearbook 2025
Lupin Ltd. has been included in the S&P Global Sustainability Yearbook 2025 for the second consecutive year, recognising its strong commitment to sustainability and improved Corporate Sustainability Assessment (CSA) score.
Global Pharma | 27/02/2025 | By Manvi | 544
Abzena Welcomes Taylor Boyd as New CBO
Boyd has a strong track record of success within the life sciences and CDMO industry, primarily in strategic transactions and capital-raising activities.
Global Pharma | 27/02/2025 | By Aishwarya | 796
MediBeacon Transdermal GFR System Receives Device Approval in China
MediBeacon Inc. announced the National Medical Products Administration (NMPA) in China has approved the MediBeacon® TGFR Monitor and TGFR Sensor for the assessment of kidney function in patients with normal or impaired renal function.
Global Pharma | 26/02/2025 | By Manvi | 1204
Nimbus Therapeutics Hits Preclinical Research Milestone with Lilly
Throughout their collaboration, Nimbus has leveraged its computational approaches and structure-based drug design capabilities to help overcome these historical obstacles.
Global Pharma | 26/02/2025 | By Aishwarya | 470
Averto Medical's ColoSeal ICD System Earns FDA Breakthrough Device Designation
Averto Medical, a clinical-stage medical device company pioneering minimally invasive gastrointestinal care, announce that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its ColoSeal™ Intraluminal Colonic Diversion (ICD) System.
Global Pharma | 26/02/2025 | By Manvi | 742
PharmSight to Expand Globally with New Strategic Hub Launch in Boston
PharmSight plans to broaden its global footprint by opening new offices in Europe and the Middle East and launching an innovation center dedicated to AI-driven solutions.
Global Pharma | 26/02/2025 | By Aishwarya | 660
Thermo Fisher Scientific Plans to Acquire Solventum Purification and Filtration Business
Solventum’s Purification & Filtration business is a provider of purification and filtration technologies used in the production of biologics as well as in medical technologies and industrial applications.
Global Pharma | 26/02/2025 | By Aishwarya | 601
Under the terms of the expanded MOU, WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs.
Global Pharma | 25/02/2025 | By Manvi | 267
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy